News | Cardiovascular Business | February 10, 2017 | Jeff Zagoudis

Rep. Tom Price Confirmed as New Health and Human Services Secretary

Price expected to lead executive branch efforts to roll back Affordable Care Act

Rep. Tom Price, confirmed, Health and Human Services, HHS, new secretary

February 10, 2017 — Rep. Tom Price was confirmed by the U.S. Senate as the new secretary of the Department of Health and Human Services (HHS) by a 52-47 vote early Friday morning.

The Georgia representative, a former orthopedic surgeon, will now be the leader of a department with a reported annual budget of more than $1 trillion. He is expected to be a strong ally for President Donald Trump in repealing and replacing the Affordable Care Act (ACA).

He will be the first physician to lead HHS since 1993, according to the New York Times.

Price’s selection by President Donald Trump was hotly contested by Senate Democrats led by Sen. Bernie Sanders of Vermont and Sen. Ron Wyden of Oregon. They expressed concern about Price’s desire to roll back the Medicare and Medicaid programs, potentially impacting insurance coverage for millions of Americans. During his tenure as chairman of the House Budget Committee, Price backed proposals to shift the financial structure of Medicare from an open-ended commitment to fixed block grants for states to apply as desired.

Opponents also took issue with the congressman actively trading shares he owned in healthcare companies while serving on committees that helped direct healthcare policy.

Price has been one of the more vocal critics of the ACA, and previously authored the ACA-alternative Empowering Patients First Act of 2015. Provisions of the bill include:

  • Age-adjusted tax credits to purchase health insurance on the individual market;
  • Allowing individuals to opt out of Medicare, Medicaid, Tricare (a U.S. Department of Defense Military Health System program) and VA benefits, and purchase individual health plans with a tax credit;
  • Incentives for participating in health savings accounts; and
  • Eliminating regulations that forbid the sale of insurance policies across state lines.

President Trump has previously promised that he will not roll back Medicare.

For more information: www.hhs.gov


Related Content

News | Cardiovascular Business

July 29, 2024 — Edwards Lifesciences announced investments that reflect the company’s deep commitment to advancing ...

Home July 29, 2024
Home
News | Cardiovascular Business

July 18, 2024 — Circle Cardiovascular Imaging, a developer of artificial intelligence (AI)-driven cardiovascular imaging ...

Home July 18, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Guidehealth, an artificial intelligence (AI)-enabled healthcare services company, has announced a ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Edwards Lifesciences announced it has exercised its option to acquire Innovalve Bio Medical Ltd., an ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 11, 2024 — Medical device company R3 Vascular Inc., developer of novel, best-in-class bioresorbable scaffolds for ...

Home July 11, 2024
Home
News | Cardiovascular Business

July 9, 2024 — Disparities in cardiovascular disease outcomes between urban and rural areas continue to widen, yet ...

Home July 09, 2024
Home
Feature | Cardiovascular Business

The DAIC team wishes you a safe and happy 4th of July!

Home July 04, 2024
Home
News | Cardiovascular Business

July 3, 2024 — Over the past decade, 342 cardiology clinics have been acquired by private equity firms, with over 94% of ...

Home July 03, 2024
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

From FDA approvals to new clinical trials, here is a look at DAIC's top-read content during the month of June: 1 ...

Home July 02, 2024
Home
News | Cardiovascular Business

July 1, 2024 — CVRx, Inc., a commercial-stage medical device company, announced three additions to its senior leadership ...

Home July 01, 2024
Home
Subscribe Now